-
R&D News | Sinopeg’s Key Excipient for Nucleic Acid Drug Delivery, DSPE-PEG-MAL, Reaches Another Milestone – CDE Filing Completed!
June 8,2026.
Recently, Sinopeg’s LNP lipid excipient product, DSPE-PEG-MAL(NH4+)-2K, has successfully completed pharmaceutical excipient filing with the Center for Drug Evaluation (CDE) of the National Medical Pro...
View More
-
The Right Cold Precursor Can Make or Break Your Radiopharma Program
July 21,2026.
In radiopharmaceutical R&D, non-radioactive precursors are the critical starting point. Their quality, availability, and modular flexibility directly impact your timeline from hit to IND-and ultim...
View More